PMC:7396557 / 34036-34263
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T209 | 71-79 | SP_10 | denotes | SARS-CoV |
| T210 | 169-173 | SP_9 | denotes | MERS |
| T54500 | 71-79 | SP_10 | denotes | SARS-CoV |
| T16827 | 169-173 | SP_9 | denotes | MERS |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T215 | 71-79 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T216 | 71-75 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T305 | 54-62 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T306 | 179-187 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T307 | 191-192 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T278 | 44-53 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T264 | 0-227 | Sentence | denotes | In vitro experiments have shown significant antiviral activity against SARS-CoV, AIV H7N9, dual H1N1/H3N2, together with inhibition of Middle East Respiratory Syndrome (MERS)-CoV activity to a certain degree (Yao et al., 2020). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1020 | 71-79 | Species | denotes | SARS-CoV | Tax:694009 |
| 1021 | 85-89 | Species | denotes | H7N9 | Tax:333278 |
| 1022 | 169-178 | Species | denotes | MERS)-CoV | Tax:1335626 |
| 1034 | 81-84 | Species | denotes | AIV | Tax:11309 |
| 1039 | 135-167 | Disease | denotes | Middle East Respiratory Syndrome | MESH:D018352 |